SCHEMBL11940422

SCHEMBL11940422

CCCCN(CCCCO)c1ccc(/C=C/c2cccs2)c(OCc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.44
SLC16A3 O15427 2/20 0.37
SLC16A1 P53985 2/20 0.37
HDAC8 Q9BY41 1/20 0.37
APP P05067 2/20 0.36
ATG4B Q9Y4P1 1/20 0.35
C5AR1 P21730 1/20 0.34
ALOX5 P09917 2/20 0.33
PSEN1 P49768 2/20 0.33
NR1H2 P55055 2/20 0.33
NR1H3 Q13133 2/20 0.33
FLT3 P36888 2/20 0.33
BCHE P06276 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
PTGER1 P34995 1/20 0.33
PTGER4 P35408 1/20 0.33
PTGER3 P43115 1/20 0.33
PTGER2 P43116 1/20 0.33
PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28277466 0.95 BACE1 (0.43) BACE1HDAC8C5AR1FLT3PTGER1
SCHEMBL11934280 0.94 BACE1 (0.44) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL10010017 0.94 BACE1 (0.46) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL10010014 0.94 BACE1 (0.46) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL12837173 0.86 BACE1 (0.43) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL11934282 0.86 BACE1 (0.45) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL10010288 0.86 BACE1 (0.45) BACE1SLC16A3SLC16A1HDAC8APP
SCHEMBL10010378 0.84 BACE1 (0.37) BACE1SLC16A3SLC16A1HDAC8ATG4B
SCHEMBL10011228 0.84 BACE1 (0.37) BACE1SLC16A3SLC16A1HDAC8ATG4B
SCHEMBL12837175 0.83 LMNA (0.41) SLC16A3SLC16A1APPATG4BALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172599-A1 SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172599-A1 SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME OGFOD1, OCIAD2, OCIAD1 BACE1 4124/4885SLC16A3 3538/4885SLC16A1 4423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.